Hannah Kuchler
Hannah Kuchler is the US pharma and biotech correspondent at the Financial Times. She reports on pharma, biotech, and healthcare. After covering Silicon Valley for over five years, she's now focusing on how technology is transforming our health.
Latest Commentary & Analysis
COVID-19 Vaccine Rollout Offers Hope, Eventually